Winter Park, Florida — November 19, 2025 — Leads & Copy — ADIA Nutrition, Inc. (OTCQB: ADIA) will host a live webinar tomorrow, Thursday, November 20, 2025, at 6:30 PM EST, in partnership with HSCT Warriors. The webinar is open to shareholders, supporters, and potential investors.
The webinar will focus on Hematopoietic Stem Cell Transplantation (HSCT) as a treatment for Multiple Sclerosis (MS) and other autoimmune conditions.
Dr. Evan Thomas, MD, PhD, Medical Director of Adia Med and Director of the Adia Med HSCT Program, will be the guest speaker. He will discuss the science behind HSCT, patient outcomes, and Adia Med’s approach to bringing this therapy to U.S. patients in a compliant, physician-led manner.
Webinar details:
Date: Thursday, November 20, 2025
Time: 6:30 PM EST
Registration: https://us02web.zoom.us/webinar/register/4017629068254/WN_S9OsJomHQ5aKcWQivjZL4g
Larry Powalisz, CEO of ADIA Nutrition, shared his personal experience with MS and HSCT. He said he was diagnosed with MS over five years ago and was told he would be in a wheelchair within three to five years. After undergoing HSCT in Mexico, he regained his mobility. Powalisz stated that ADIA Nutrition is proud to bring this proven therapy to patients in the U.S. safely, legally, and under full physician oversight. He added that the webinar is an opportunity to hear directly from Adia Med’s medical director.
ADIA Nutrition encourages clinic owners and healthcare practitioners interested in licensing the Adia Med name or integrating Adia’s regenerative therapies to contact them directly. Strategic partnerships are also welcome.
ADIA Nutrition Inc. (OTCQB: ADIA), based in Winter Park, Florida, is a publicly traded company specializing in stem cell and regenerative products. Its lab division, AdiaLabs LLC, is expanding to include insurance-billable wound care products. Adia Med clinics offer orthopedic, pain management, and wound repair services, including stem cell therapies, platelet-rich plasma (PRP), therapeutic plasma exchange (TPE), and autologous hematopoietic stem cell transplantation (aHSCT).
The company generates revenue through service fees, product sales, equity stakes, and insurance billing for healthcare treatments. ADIA Nutrition Inc. also invests in aligned businesses such as Cement Factory LLC, a nutrition and supplement company.
The company is committed to revolutionizing healthcare by expanding access to regenerative solutions and holistic wellness through partnerships and adherence to FDA-approved lab protocols.
Larry Powalisz can be contacted at ceo@adiamed.com or by phone at 321-788-0850.
Source: ADIA Nutrition Inc.
